James Walsh

Reporter | Medical Technology
Phone: 612-673-7428
James Walsh covers medical technology companies such as Medtronic and St. Jude and innovations.

Recent content from James Walsh

Medtronic sheds 2,000 jobs worldwide, 500 in Minnesota

The layoffs come at a time when earnings were better than expected.

Updated: May 22, 2013, - 08:31 AM

Minneapolis Heart Institute part of trial for dissolving stent

Absorb, by Abbott Labs, could be a significant upgrade, maybe transformational, if it works.

Updated: May 08, 2013, - 09:13 PM

Medtronic: Overtightening screw can damage wire that delivers therapy to brain

Two surgeons agree with manufacturer that damage to a deep brain stimulation device wouldn’t be life-threatening.

Updated: May 07, 2013, - 05:14 PM

Medtronic's new device sparks war of words with Boston Scientific

Shortly after announcing FDA approval, Medtronic responded to jabs from rival Boston Scientific.

Updated: May 07, 2013, - 02:53 PM

Obituary: James Mickman, 59, physician and humanitarian

Somewhere between his a-little-wild-and-crazy childhood and his discharge from the U.S. Navy as a hospital corpsman, Dr. James Mickman decided...

Updated: April 20, 2013, - 09:25 PM

Heart devices send revenue down slightly at St. Jude

But profit beat forecasts. Officials predict accelerating sales growth the rest of the year.

Updated: April 17, 2013, - 09:10 PM

Study bolsters CSI technology to treat heart blockages

St. Paul-based CSI saw its stock climb after positive study results were presented in San Francisco.

Updated: March 11, 2013, - 09:32 PM

Small med-tech firms say FDA delays hurt innovation

Uncertainty chases away venture capital, some execs say, but others say the FDA is only doing its job.

Updated: February 09, 2013, - 09:18 PM

Boston Scientific to cut up to 1,000 more jobs

The new layoffs will bring total cuts to 10 percent of the workforce. Cuts in Minnesota aren't yet known.

Updated: January 30, 2013, - 11:30 AM

Best of the business blogs: Kips Bay Medical to enroll more patients in U.S. feasibility trial

A local medical technology company, Kips Bay Medical, announced Wednesday that it has received approval from the Food and Drug Administration to enroll additional patients into its eMESH I clinical feasibility trial.

Updated: January 26, 2013, - 05:54 PM

Result Per Page
  • 50°
  • 54/43
  • Cloudy

The Drive: Metro traffic

ADVERTISEMENT

Connect with twitterConnect with facebookConnect with Google+Connect with PinterestConnect with PinterestConnect with RssfeedConnect with email newsletters
Search by category

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT